Table 3.

Participant and treatment characteristics for each study arm

	BPTG@HOME	Care-as-usual	Waiting list
Age of child in years (M (SD) [range])	8.2 (1.5) [6.0–11.1]	9.0 (1.3) [6.0–11.1]	9.4 (1.4) [7.0–12.1]*
Full scale IQ of child (M (SD) [range])	93.4 (11.1) [71–119]	84.8 (14.0) [73–118]	95.5 (12.0) [72–199]
Educational level mother (Frequency of those with low level, middle level, and high level)	11, 13, 2	8, 14, 2	8, 11, 4
Duration of treatment in months (M (SD) [range])	5.3 (1.7) [1.3–8.8]	13.9 (5.4) [5.7–28.8]*	4.3 (.4) [3.8–5.5]*
Total number of sessions (M (SD) [range])	13.1 (5.1) [1–17]	29.8 (18.0) [1–87]*
Changes in medication use during treatment (Frequency of lowered dosage, increased dosage, and change of type of medication)	5, 2, 4	2, 2, 1	1, 3, 0
Other psychosocial care at pre-treatment (mean frequency of sessions per month (SD) [range])	3.6 (4.7) [0–16.5]	2.5 (4.4) [0–16]	2.4 (5.1) [0–24]
Care focused on parents	2.4 (3.9) [0–13]	1.8 (4.0) [0–16]	1.6 (5.1) [0–24]
Care focused on child	1.2 (2.1) [0–8]	0.8 (2.0) [0–8]	0.8 (1.4) [0–4]
Other psychosocial care at post-treatment (mean frequency of sessions per month (SD) [range])	3.7 (4.5) [0–20]	4.8 (7.10) [0–23]	-
Care focused on parents	2.7 (4.1) [0–17]	4.2 (7.1) [0–23]	–
Care focused on child	0.9 (1.9) [0–8]	0.6 (1.5) [0–5]	–
Other psychosocial care at follow-up (mean frequency of sessions per month (SD) [range])	3.8 (3.9) [0–16]	3.0 (2.9) [0–8]	–
Care focused on parents	2.2 (3.7) [0–16]	1.2 (1.4) [0–4]	–
Care focused on child	1.6 (2.1) [0–6]	1.8 (3.0) [0–8]	–

M mean, SD standard deviation, No number of cases

*Significant difference (p < 0.05) with the BPTG@HOME group according to ANOVA, all other comparisons (according to ANOVA or chi-square test) were not significant